DrugPatentWatch Database Preview

Details for Patent: 9,345,714

Which drugs does patent 9,345,714 protect, and when does it expire?

Patent 9,345,714 protects CIPRODEX and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 9,345,714

Title:	Method of treating middle ear infections
Abstract:	Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.
Inventor(s):	Wall; G. Michael (Fort Worth, TX), Conroy; Peter J. (Fort Worth, TX)
Assignee:	Alcon Pharmaceuticals Ltd. (Fribourg, CH)
Application Number:	14/838,637
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 9,345,714

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Novartis Pharms Corp	CIPRODEX	ciprofloxacin; dexamethasone	SUSPENSION/DROPS;OTIC	021537-001	Jul 18, 2003		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT OF ACUTE OTITIS MEDIA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 9,345,714

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,402,805	Method of treating middle ear infections	➤ Sign Up
8,846,650	Method of treating middle ear infections	➤ Sign Up
9,149,486	Method of treating middle ear infections	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 9,345,714

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	313328	➤ Sign Up
Australia	2002333671	➤ Sign Up
Brazil	0212898	➤ Sign Up
Canada	2459930	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 9,345,714

For more information try a trial or see the plans and pricing